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ABSTRACT
Background: Aortic aneurysms and dissections (AD) are common in aging populations,
and their development is tightly associated with vascular inflammation. Aortic dissection
and rupture are associated with high mortality. Currently, there is no effective drug
treatment for AD progression and rupture except surgical treatment. Although ketone
bodies have an anti-inflammation effect, it remains unclear whether ketone restrains AD
and the risk of rupture.
Methods: C57BL/6J mouse underwent β-aminopropionitrile (BAPN) treatment with
drinking water for 28 days, followed by angiotensin II (Ang II) mini-pump implantation for
3 days to induce AD. Ketone-ester (KE) was administered in drinking water starting at
17days after initiation of BAPN treatment. There were four groups: Sham, BAPN+Ang II,
BAPN+Ang II+KE 20 g/L, and BAPN+Ang II+KE 50 g/L. The blood ketone level was
monitored by a Precision Xtra meter. Ultrasound was employed to measure the aorta
strain.
Results: KE treatment (both 20 g/L and 50 g/L) reduced the incidence of both thoracic
aortic dissection and abdominal aortic dissection. KE at 50 g/L increased the survival rate
of BAPN plus AngII-treated mice. KE treatment did not reverse the Ang II-induced aortic
stiffness demonstrated by reduced aorta strain. BAPN and KE did not affect mice weights,
but Ang II slightly reduced the mouse body weight. BAPN and KE treatment had no effect
on water consumption. These results suggest that ketone appears to decrease aortic
dissection and risk of rupture and provides a potential therapeutic strategy for aortic
dissection.
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1 INTRODUCTION
The vascular system consists of arteries (carrying the oxygenated blood),
capillaries (the level at which there is an exchange of blood nutrients, oxygen, and waste
products), and veins (receiving the deoxygenated blood). These are important for tissue
homeostasis through the provision of oxygen and nutrients, and the removal of waste
products. (1). The vascular smooth muscle extracellular matrix that consists of collagen
and elastin is important for maintaining mechanical integrity. Lysyl oxidase (LOX) and
lysyl oxidase-like 1-4 (LOXL1-4) enzymes play a key role in the remodeling of vascular
smooth muscle extracellular matrix (ECM). These enzymes are important for connecting
the elastin with the collagens in the ECM. The deficiency of these enzymes can result in
disrupted elastin and collagen cross-links. (1,2,3).
β-aminopropionitrile (BAPN) and penicillamine are potent inhibitors of lysyl oxidase
(LOX). (5). This results in a deficiency of enzymes and a lack of cross-linking between
the elastin and collagen in the smooth muscle extracellular matrix to form desmsine.
BAPN can also induce systemic inflammation by acting on the immune system. This
enables an inflammatory response and causes vascular damage. (4,5). Many studies
have demonstrated the use of BAPN with angiotensin II (AngII) Infusion to promote aortic
damage. However, the use of BAPN without angiotensin II infusion can also induce aortic
damage formation. (4)
Aortic diseases are life-threatening and associated with high mortality. The cause
of most of these is unknown, but the risk increases with high blood pressure and
inflammation. The persistent exposure of vascular endothelium to inflammatory
stress/chemokines facilitates the development of aortic aneurysms and dissections. (2,4).
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The aortic smooth muscle cells contract to regulate the lumen size based on blood
pressure. However, increased blood pressure and inflammatory stress promote
dysfunction of the vascular endothelium. Aortic aneurysms are defined as the increased
luminal size of the aorta, associated with a risk of uncontrolled bleeding due to rupture of
the aorta. Aortic dissections are defined as the bleeding into the medial layers of the aorta
resulting in organ dysfunction. (2,4).
Ketone bodies (acetoacetate, β-hydroxybutyrate, acetone) are produced by
hepatic mitochondria from acetyl CoA and transported to other tissues like the heart,
brain, and muscles for energy production when fatty acids and carbohydrates are not
available (During fasting or strenuous exercise). Acetoacetate and β-hydroxybutyrate are
the major ketone bodies used by the cardiovascular system. The ketone body, especially
β-hydroxybutyrate (β-OHB) has been found in cardiovascular disease metabolism as an
energy source. This is an important adaptive response to stress during the pathological
progression of the disease. It has also been demonstrated to decrease the production of
reactive oxygen species and autophagy. The increased levels of β-OHB before
cardiovascular injury result in reduced damage to the system in an animal. (6,7,8). AAD
(abdominal aortic dissection) may be associated with high energy consumption and
limited ability to store ATP, there is a need for a continuous supply of efficient exogenous
substrate for energy production. (9,10). It has been shown that a prolonged caloric
restriction decreases inflammatory response, however, the effect of Ketones and other
related energy producing substrates on the immune system is not well understood. (11).
The aim of this study is to test the anti-inflammatory function of β-OHB in the prevention
of aortic aneurysm and dissection.
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2 METHOD AND MATERIALS
2.1 Experimental Animal
Five weeks old wild-type C57BL/6J mice were used with each weighing an average
of 18 g. The animals were all maintained under a light/dark cycle (12/12 h). The mice ate
and drank according to the experimental design. Georgia State University’s Animal Care
and Use Committee approved this study.
2.2 Reagents
β-aminopropionitrile (BAPN, Product number; A0796), and Ketone-ester (D-BHB
1-3 butanediol monoester) purchased from TCI and ketoneaid in the United States
respectively.
2.3 Animal Model
The animals were divided into two groups randomly, 10 in the control group and
35 in the model group. In the model group, BAPN at 3 g/L was added to the drinking water
for 28 days (about 4 weeks). Body weight was measured every alternate day (2 days).
On the seventeen days of the study, 5 ml (about 0.17oz) per day per mouse of 20
g pure Ketone-ester (KE)/L (40 g/L drinking water to supply ketone), 20 g BW per mouse.
5 g KE/kg daily for 2 weeks. During the experiment, non-fasting β-OHB levels were
periodically measured using a Precision Xtra meter. On the 28th day of the experiment, a
subcutaneous infusion of Angiotensin II using an osmotic pump of 1000 ng/kg/min for 3
days (Figure 1).
The control group fed on the commercial feed (pellets) and drank autoclaved water
throughout the research study.

EFFECT KETONE ON BAPN-INDUCED VASCULAR REMODELING

4

Figure 1: Scheme of animal treatment with BAPN, KE, and Ang II

2.4 Echocardiography
The aorta vessel function was examined using Vevo 3100 echocardiography
machine and an MS 550D probe (22-55 MHz) under anesthesia with 1% to 1.5%
anesthetics (Isoflurane) in a 100% atmosphere gas chamber.
Mice were anesthetized and placed in a warm pad in a supine position. Warmed
ultrasound gel was applied, and the probe was positioned to visualize the abdominal aorta
at the level of the diaphragm and the branching of superior renal arteries.
M-mode tracings of aortic crossing view were recorded. Aortic Strain (Vascular
Stiffness) was calculated using the radial strains formula; ε=(L−Lₒ)/Lₒ, the percent ratio
of the systolic-diastolic diameter change, and diastolic diameter of the aorta. Doppler
imaging was also carried out to determine the velocity of blood through the vessels.
3. RESULTS
3.1 Ketone-ester has no Effect on Animal Water Consumption
We first tested the effect of Ketone-Ester (KE) on water consumption of mice. As
shown in Figure 2, KE at either 20 g/L or 50 g/L had no clear effect on the water
consumption in mice.

EFFECT KETONE ON BAPN-INDUCED VASCULAR REMODELING

5

Figure 2. The effect of reagents on animal water consumption. Mice reduced water consumption after
application of BAPN, water consumption was restored partially with KE (20 and 50 g KE) application in
drinking water.

3.2. Effect of Ketone-ester on Body Weight
As shown in Figure 3a, BAPN and BAPN plus ketone-ester did not change the
body weight of both male and female mice compared with the sham group. Although
angiotensin II treatment slightly decreased the body weight of mice treated with BAPN,
Ketone-Ester treatment blocked angiotensin II-mediated body weight reduction (Figure
3b).

a.
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b.
Figure 3. Body weight among mice groups. a. Body Weight at day 28 (just before Angiotensin II
implantation). b. Body weight after Angiotensin II implantation (at day 31).

3.3 Blood Ketone Levels During Animal Experiments
As previously reported, fasting clearly increased the blood ketone levels (Figure
4b & c). Blood ketone levels were increased after KE application (Figure 4a-4c), but only
when the animal up took the water. Ketone levels tested during daytime in the 20 or 50
KE groups, especially in the morning around 11:00 am, did not show any different
compared with the BAPN alone-treated group (Figure 4b). However, when the light was
off, the ketone levels dramatically increased since the animals started to drink the KEcontained water (Figure 4c). Therefore, the ketone levels might be measured at least 2
hours after the light off.

a.
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c.
Figure 4. Blood ketone levels. a: Blood ketone levels measured at three time points (11:00 am, 4:00 pm,
and 11:00 pm) at age (5+3) weeks. b: Blood ketone level measured at daytime (about 11 am). c: Blood
ketone level measured at night (about 11 pm).

3.4 Survival Rate of Mice and Aortic Dissection
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As shown in Figure 5, low dose of KE application (20 g/L) did not improve the
survival rate compared to BAPN+Ang II group. Medium dose of KE application (50 g/L)
improved survival rate: no mice died in the 50 g/L KE group. Both 20 g/L and 50 g/L KE
dramatically decreased the number and percentage of thoracic aortic dissection (TAD)
(Figure 6a & b). Furthermore, two dose KE also clearly decreased the number and
percentage of abdominal aortic dissection (AAD) (Figure 7a & b).

Figure 5. Survival rate of mice among the control group and model group. Survival rate (%) = total alive
mice number by the end of the experiment (at 31 days)/total mice number in that group.
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a.

b.
Figure 6. KE application reduces the incidence of TAD. 20KE and 50KE groups had no difference. a:
Number of animals with TAD incidence. b: Percentage of TAD incidence. TAD: thoracic aortic dissection.
a vs b, A vs B, P<0.05
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a.

b.
Figure 7. KE application reduces the incidence of AAD. 20KE and 50KE groups had no difference. a:
Number of animals with AAD incidence. b: Percentage of AAD incidence. AAD: abdominal aortic
dissection. a vs b, A vs B, P<0.05

3.5 Ketone-ester Treatment does not Alleviate Aorta Stiffness
Since Ang II can increase aortic stiffness, we want to know whether ketone reveres
the AngII-mediated aortic stiffness. We used ultrasound to measure the aorta strain at
two locations: at the level of diaphragm (Figure 8) and the level of renal bifurcation
(Figure 9). The aortic strain decreased in all BAPN+AngII, BAPN+AngII+KE20, and
BAPN+AngII+KE50 groups. However, either BAPN or KE did not alter the aortic strain
at the two tested locations (Figure 8 and Figure 9). Male and female mice did not show

EFFECT KETONE ON BAPN-INDUCED VASCULAR REMODELING
differences in arterial strain. These data suggest that KE treatment does not alleviate
the aorta stiffness induced by Ang II.

a.

b.
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c.
Figure 8. KE does not alleviate the vessel strain at the level of the diaphragm. a: Percentage of aortic
strain at the level of the diaphragm. b: Percentage of aortic strain at the level of the diaphragm on day 28.
c: Percentage of aortic strain at the level of the diaphragm on day 31. a vs b, P<0.05

a.

EFFECT KETONE ON BAPN-INDUCED VASCULAR REMODELING

13

b.

c.
Figure 9. KE does not alleviate the vessel strain at the level of the renal bifurcation. a: Percentage of
aortic strain at the level of the renal bifurcation. b: Percentage of aortic strain at the level of the renal
bifurcation on day 28. c: Percentage of aortic strain at the level of the renal bifurcation on day 31. a vs b,
P<0.05

4. DISCUSSION
This study shows that ketone ester application reduces the incidence of TAD and
AAD in mice. The mice were grouped into four groups; Sham (control), BAPN+Ang II,
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BAPN+Ang II+KE 20g/L, and BAPN+Ang II+KE 50g/L. A higher dose of ketone ester was
avoided because it could lead to reduced water consumption, animal dehydration, and
cause death of the animals. Blood ketone levels were measured at three time points
(11:00am, 4:00pm, and 11:00pm). Ketone levels measured during daytime (11:00am and
4:00pm) did not increase significantly which might be due to low mice activity during the
daytime. Ketone levels measured during nighttime (11:00pm) are increased, more likely
due to the regular mice active period. The measurement was done at age 8 weeks (about
2 months) before the Angiotensin II pump were implanted. The study shows that the use
of low dose Ketone ester (20 g/L) did not improve survival rate compared to the
BAPN+Ang II group. However, the use of medium dose (50 g/L) improves survival rate.
The survival rate is determined by the total number of alive mice number by the end of
the experiment (at 31 days) divided by the number of mice in that group. Thoracic aortic
dissections and abdominal aortic dissections incidences were reduced with the
application of ketone ester. The vascular strain (arterial flexibility) reduced after the
application of angiotensin II. The stiffness of the vascular was not alleviated with ketone
ester. Male and female mice did not show a difference in arterial strain. The body weight
had no significant difference among mice groups, but Angiotensin II pump implantation
slightly reduced their body weight. There was a reduction in water consumption after the
application of BAPN and it was restored partially with ketone ester application.
This study has few limitations. It is not doubtful that animal models are valuable for
biomedical research, but whether animal models are predictive for humans is disputable.
There is no current effective aortic aneurysm drug therapy. The only effective treatment
is surgical intervention (open surgical or endovascular stent placement). Anti-
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inflammatory drugs, protease inhibitors, stem cell therapies, anti-platelet, anticoagulant
drugs, and renin angiotensin system inhibitors may reduce the diameter of reestablished
aortic aneurysm in mouse models and reduce the risk of aortic rupture in mice. (12)
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Coordinated patient referral to tertiary healthcare facilities as needed

03/2014 - 11/2016: Medical Officer/Medical Director, Nigerian Police Medical Services,
Kaduna, Nigeria
•
•
•
•
•

Coordinated medical teams to achieve daily goals.
Managed the facility's budget
Worked with other medical staff in this under-served community health center in
the general outpatient and in-patient units
I reviewed, discharged, and followed up with patients and performed basic medical
procedures.
Managed various acute and chronic medical conditions such as hypertension,
headaches, seizure disorder, diabetes, acute diarrhea, delirium tremens, alcohol,
and other drug intoxication, and provided a referral to tertiary centers for complex
cases.

03/2013 - 12/2016: Medical Officer, Garden City Specialist Hospital, Kaduna, Nigeria
•
•
•
•
•

Worked as a primary care physician
Attended to patients in the inpatient and outpatient clinic units
Managed emergency medical, psychiatry, obstetric, pediatric, and surgical cases
Coordinated patient referrals to secondary and tertiary healthcare facilities as
needed.
Performed minor procedures such as insertion of a urinary and intravenous
catheter, intramuscular and subcutaneous injections, phlebotomy, lumbar
puncture, suturing of cuts, and episiotomies

03/2012 - 02/2013: Medical Officer, Medical Center, Nigerian Defense Academy, Kaduna,
Nigeria
•
•
•
•
•

A military university hospital.
Worked as a primary care physician
Hand-on management of medical, obstetrics, surgical, and pediatric cases in
emergent and non-emergent settings
We managed various acute and chronic medical conditions such as hypertension,
headaches, seizure disorder, diabetes, acute diarrhea, delirium tremens, alcohol,
and other drug intoxication.
Referred patient to secondary and tertiary healthcare facilities as needed.

11/2011 - 02/2012: Clinical Intern, Ahmadu Bello University Teaching Hospital, Zaria,
Nigeria
•
•

The clinical internship is a year-long and required for full certification as a general
practice physician in Nigeria.
Ahmadu Bello University Teaching Hospital is a 550 bedded hospital.
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•
•
•
•
•

I acquired basic clinical skills under the supervision of seasoned health
professionals in a high patient-load tertiary healthcare set-up.
I worked as the first doctor on call in the emergency and on the inpatient unit,
rotated under the supervision of attending in internal medicine, surgery, pediatric,
obstetric, and gynecology.
Performed minor procedures, assisted in surgeries, and participated in scholarly
activities.
Organized and led weekly case presentations and teaching rounds for medical
students and supervised them.
Organized and participated in monthly departmental morbidity/mortality meetings,
case presentations, and medical conferences organized by the hospital.

09/2011 - 11/2011: Clinical Observer, Garden City Specialist Hospital, Kaduna, Nigeria
•
•
•

Observed medical practices, procedures, and patient care
Took patient history and discussed cases with the attending physician.
Fully supervised while examining patients.

06/2011 - 09/2011: Clinical Observer, Balogun Hospital and Maternity, Ilorin, Nigeria
•

Shadowed an obstetrician during clinic chart reviews, floor rounds, and surgeries

Research Experience
09/2022 - Present: Research Assistant, Center for Molecular and Translational Medicine,
Atlanta, GA, United States of America
Research Advisor: Dr. Ping Song
•

I work at the Center for Molecular and Translational Medicine, Georgia State
University, Atlanta, Georgia.

Research Title: Humane ApoE2 Endows Stronger Contractility in Rat Cardiomyocytes
Enhancing the Heart Functions.
•
•
•
•
•
•
•
•

Activities Involved:
Non-invasive echocardiography was performed on rats.
Arterial strain analysis was performed on rats' abdominal aorta using ultrasound.
Rats' heart weight was measured after euthanization.
Isolation and culture of rats' cells
Histology and microscopy of sliced rats' hearts
Cardiomyocytes contractility and intracellular Ca2+ signaling
Western blot assays of protein from rats' hearts

Research Title: The Effect of Ketone on Beta-aminopropionitrile-induced Vascular
Remodeling Activities Involve: Research in progress.
03/2022 - Present: Research Assistant, Larkin Community Hospital, South Miami, FL,
United States of America
Research Advisor: Dr. David Leszkowitz
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•
•
•
•
•
•

At the Larkin Community Hospital Research team, I am currently involved in
research projects related to addiction medicine.
One of the projects is the association between smartphone addiction and binge
eating.
Involve in literature reviews
Participate in the formulation of questionnaires or primary surveys for research.
Coordinate the administration of the primary surveys by the research participants.
Involve in data analysis and interpretation.

08/2018 - 08/2021: Research Assistant, Dept. of Public Health, Western Kentucky
University, Bowling green, KY, United States of America
Research Advisor: Dr. Michelle Reece
•
•
•
•
•
•
•
•
•
•

I was involved in some funded scientific research projects and was critical to the
successful execution of the Western Kentucky University Refugee Health Summit
in April 2019.
The first project was a Provider Needs Assessment in Refugee Health Services.
The second was an Evaluation of the Implementation of Culturally and
Linguistically Appropriate Services in the Southeastern United States.
Lastly, Cross-sectional Analysis of the Risk Factors for Multiple Hospitalizations
Among Female Medicaid Beneficiaries.
Activities involved:
Data collection and analysis.
Used statistical software (SPSS, SARS, and Excel) to analyze data.
Planned and coordinated focus group discussions.
Planned and coordinated coaching sessions for research participants
Participated in the informed consent process, ensuring that human subjects, their
families, and other health care providers clearly understand what is expected of
and from them while participating in the project.

07/2010 - 01/2011: Student Researcher, Dept. of Community Medicine, University of
Ilorin, Nigeria
Research Advisor: Professor T. m. Akande
•

•
•

The World Health Organization (WHO) supported a program in which
questionnaires were used to collect data on health status, as well as knowledge,
attitude, and practices of the Pakata people on refuse management and the health
implications.
The analyzed data and the results were presented to the state ministry of health.
The final report was sent to the World Health Organization.

PUBLICATIONS:
•

Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2022, Aug). Cross-Sectional Analysis of the Risk Factors for
Multiple Hospitalizations among Female Medicaid Beneficiaries Pub Status:
Submitted.
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•

Wu Y., Zhao F., Ibrahim A., Yu C., Carr S., & Song P. (2022, Sep). Humane ApoE2
endows stronger contractility in rat cardiomyocytes enhancing the heart function
Pub Status: Submitted.

Online Publication
•

Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2019, November 04). Personal hygiene and the implications to
health
service
among
refugees
in
the
USA.
https://apha.confex.com/apha/2019/meetingapp.cgi/Paper/446472 Pub Status:
Published.

Poster Presentation
•

•

•

•

•

Ibrahim A. D., Reece M., Mkanta W., (2022, October 13). Healthcare Providers
Perspectives on Types of Acculturations and Substance Abuse Behavior Among
Refugees
[Poster
presented].
The
Mental
Health
Services
Conference/Washinghton, DC, USA
Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2018, November 15). Mental Health and Healthcare Access
among Refugees in the USA. [Poster presented]. Kentucky Rural Health
Association 20th Annual Conference/Bowling Green, KY, USA.
Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2019, March 15). Health Impact of Medical Interpretation
Services for Linguistic Minorities [Poster presented]. 2019 Student Research
Conference, Western Kentucky University/Bowling green, KY, USA.
Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2019, March 15). Oral Health Concerns in Refugees and
Perceived Barriers to Care [Poster presented]. 2019 Student Research
Conference, Western Kentucky University/Bowling green, KY, USA.
Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2019, June 15). Policy Implications for Mental Health Service
Utilization among Refugees in America. [Poster presented]. North American
Refugee Health Conference, /Toronto, ON, CAN.

Oral Presentation
•
•

•

Ibrahim A. D. (2011, December 11). Water and electrolyte Balance [Oral
Presentation]. Departmental Grand Round at Ahmadu Bello University Teaching
Hospital/Zaria, NGA
Ibrahim A. D. (2021, November 16). TNF-Alpha Gene Silencing Mediated by Orally
Targeted Nanoparticles Combined with IL-22 for Synergistic Combination Therapy
in Ulcerative Colitis [Oral Presentation]. Research Meeting, Institute of Biomedical
Science, Georgia State University/Atlanta, GA, USA.
Ibrahim A. D. (2022, February 22). Metformin Suppresses Diabetes Accelerated
Atherosclerosis via the Inhibition of Drp-1 Mediated Mitochondrial Fission [Oral
Presentation]. Research Meeting, Institute of Biomedical Science, Georgia State
University/Atlanta, GA, USA.
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•

•
•

Ibrahim A. D. (2022, March 03). Brain-Derived Autophagosome Profiling and
Engulfment of Nucleoid-Enriched Mitochondrial Fragment by Autophagy in
Neurons [Oral Presentation]. Research Meeting, Institute of Biomedical Science,
Georgia State University/Atlanta, GA, USA
Ibrahim A. D. (2022, June 04). Effect of Topiramate on Acid-Base Balance [Oral
Presentation]. Clinical Meeting in Avant Interventional Psychiatry/Atlanta, GA,
USA.
Ibrahim A. D. (2022, September 06). iPSC-Derived Human Microglia-like Cells to
Study Neurological Diseases [Oral Presentation]. Research Meeting, Institute of
Biomedical Science, Georgia State University/Atlanta, GA, USA.

Online Publication
•

Ibrahim A. D., Reece M., Mkanta W., Alamri A., Pope D., Tadakaluru A., Thakur
N., & Khatoon R. (2019, November 04). Personal hygiene and the implications to
health
service
among
refugees
in
the
USA.
https://apha.confex.com/apha/2019/meetingapp.cgi/Paper/446472 Pub Status:
Published.

HOBBIES & INTEREST:
•
•
•
•

I enjoy traveling, especially taking road trips.
I derive pleasure from spending time with my family and friends.
I am innovative in nature, and trying new things gives me satisfaction and
fulfillment.
I love watching soccer and playing soccer.

OTHER AWARDS/ACCOMPLISHMENTS:
•
•
•
•
•
•
•

Enterprise Design Thinking Practitioner 2022
Preventing and Managing Crisis Situation (PMCS) 2019
Certified Opioid Overdose Prevention First Responder 2019
Certified Mental Health First Aider 2019
National Youth Service Corps of Nigeria (NYSC) Award of Recognition of National
Service-2013
Member, Western African College of Physicians (PRIMARY) - 2013
Chief Intern – 2012

MEMBERSHIP AND HONORARY/PROFESSIONAL SOCIETIES:
•
•
•
•
•

Association of Nigerian Physicians in the Americas -2022
American Medical Association - 2020
American College of Healthcare Executives-2019
American Public Health Association - 2019
Nigerian Medical Association - 2011
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•

Medical and Dental Council of Nigeria -2011

